Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Astellas, Kotobuki, Merck sales and marketing update

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Kotobuki Pharmaceutical Co., Tokyo, Japan Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Endocrine/Metabolic Astellas and Merck's MSD K.K. subsidiary …

    Published on 4/28/2014
  • Chugai sales and marketing update

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Business: Cancer Chugai launched Kadcyla trastuzumab emtansine in Japan to treat inoperable or recurrent HER2-positive breast cancer. Japan's National Health …

    Published on 4/28/2014
  • Cubist sales and marketing update

    Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Business: Infectious Cubist recalled one lot of Cubicin daptomycin due to the presence of particulate matter identified as glass particles found in a single …

    Published on 4/28/2014
  • Japan Tobacco, Torii sales and marketing update

    Japan Tobacco Inc. (Tokyo:2914), Tokyo, Japan Torii Pharmaceutical Co. Ltd. (Tokyo:4551), Tokyo, Japan Business: Endocrine/Metabolic Japan Tobacco and its Torii subsidiary said Torii plans to launch Riona ferric citrate…

    Published on 4/28/2014
  • MDxHealth sales and marketing update

    MDxHealth S.A. (Euronext:MDXH), Liege, Belgium Business: Diagnostic MDxHealth said U.S. healthcare PPO network Galaxy Health Network will cover MDxHealth's ConfirmMDx for Prostate Cancer test. MDxHealth said the …

    Published on 4/28/2014
  • Quest Diagnostics sales and marketing update

    Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Business: Diagnostic Quest Diagnostics' Athena Diagnostics Inc. business unit launched in the U.S. 10 lab-developed tests based on next-generation sequencing to diagnose …

    Published on 4/28/2014
  • Response Genetics, Oregon Health & Science University sales and marketing update

    Response Genetics Inc. (NASDAQ:RGDX), Los Angeles, Calif. Oregon Health & Science University, Portland, Ore. Business: Diagnostic The university's Knight Diagnostic Institute granted Response Genetics exclusive rights …

    Published on 4/28/2014
  • Seattle Genetics, Takeda sales and marketing update

    Seattle Genetics Inc. (NASDAQ:SGEN), Bothell, Wash. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Cancer Takeda launched in Japan Adcetris brentuximab vedotin to treat patients with CD30-positive …

    Published on 4/28/2014
  • Shionogi, Viiv Healthcare sales and marketing update

    Shionogi & Co. Ltd. (Tokyo:4507), Osaka, Japan ViiV Healthcare Ltd., Brentford, U.K. Business: Infectious ViiV and Shionogi launched ViiV's Tivicay dolutegravir in Japan to treat HIV infection in combination with other …

    Published on 4/28/2014
  • Anika, J&J sales and marketing update

    Anika Therapeutics Inc. (NASDAQ:ANIK), Bedford, Mass. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Autoimmune Anika said its U.S. commercialization partner, the DePuy Synthes Mitek Sports Medicine …

    Published on 4/21/2014
  • Dr. Reddy's, Teva sales and marketing update

    Dr. Reddy's Laboratories Ltd. (NYSE:RDY), Hyderabad, India Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Neurology Dr. Reddy's and Teva launched in the U.S. generic versions of …

    Published on 4/21/2014
  • Mylan sales and marketing update

    Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Business: Endocrine/Metabolic, Generics Mylan's Mylan Pharmaceuticals Inc. subsidiary launched in the U.S. a generic version of transdermal contraceptive patch Ortho Evra …

    Published on 4/21/2014
  • Amarin, Kowa sales and marketing update

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Kowa Co. Ltd., Nagoya, Japan Business: Endocrine/Metabolic Amarin granted Kowa's Kowa Pharmaceuticals America Inc. subsidiary U.S. co-promotion rights to …

    Published on 4/7/2014
  • Bayer sales and marketing update

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Endocrine/Metabolic Bayer launched Jaydess low-dose levonorgestrel-releasing intrauterine system in the U.K. as a long-term contraceptive. The product, which costs 69…

    Published on 4/7/2014
  • HRA Pharma, Afaxys Inc. sales and marketing update

    HRA Pharma S.A., Paris, France Afaxys Inc., Charleston, S.C. Business: Genitourinary The Afaxys Pharmaceuticals division of Afaxys relaunched emergency contraceptive ella ulipristal acetate in the U.S. Afaxys has …

    Published on 4/7/2014
  • Intelligent Medical Devices, Abbott sales and marketing update

    Intelligent Medical Devices Inc., Waltham, Mass. Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Business: Diagnostic Intelligent Medical launched the IMDx VanR for Abbott m2000 test in Canada and Singapore to detect …

    Published on 4/7/2014
  • Jazz Pharmaceuticals sales and marketing update

    Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Dublin, Ireland Business: Hepatic Jazz launched Defitelio defibrotide in Germany and Austria to treat severe hepatic veno-occlusive disease (VOD) in adults and children undergoing…

    Published on 4/7/2014
  • Machaon sales and marketing update

    Machaon Diagnostics Inc., Oakland, Calif. Business: Diagnostic Machaon launched its aHUS Genetic Panel to genetically confirm atypical hemolytic uremic syndrome (aHUS). The company said the test, which costs $2,978, has…

    Published on 4/7/2014
  • Opko sales and marketing update

    Opko Health Inc. (NYSE:OPK; Tel Aviv:OPK), Miami, Fla. Business: Diagnostic Opko launched 4Kscore Prostate Cancer Test in the U.S. The laboratory developed test (LDT), which uses a panel of kallikrein biomarkers to …

    Published on 4/7/2014
  • Otsuka Pharmaceutical sales and marketing update

    Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan Business: Diagnostic On April 14, Otsuka will launch its QuickNavi Strep A rapid test kit in Japan to detect beta-hemolytic Group A Streptococcus infection.

    Published on 4/7/2014
  • Saladax sales and marketing update

    Saladax Biomedical Inc., Bethlehem, Pa. Business: Diagnostic Saladax's Saladax Biomedical Laboratories division launched the My5-FU diagnostic test in the U.S. to personalize and optimize 5-fluorouracil (5-FU) dosing. …

    Published on 4/7/2014
  • Sequenom, Synapse Diagnostics sales and marketing update

    Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Synapse Diagnostics, Hyderabad, India Business: Diagnostic Synapse launched Sequenom's MaterniT21 Plus LDT in India. The non-invasive prenatal fetal trisomy 21, 18 and 13 …

    Published on 4/7/2014
  • XDx Inc sales and marketing update

    XDx Inc., Brisbane, Calif. Business: Diagnostic XDx said health insurer Cigna Corp. (NYSE:CI, Bloomfield, Conn.) issued a positive coverage decision for XDx's AlloMap Molecular Expression Test for patients from six …

    Published on 4/7/2014
  • Aerocrine sales and marketing update

    Aerocrine AB (SSE:AERO), Solna, Sweden Business: Diagnostic Aerocrine said that Health Care Service Corp. (HCSC) will add coverage of fractional exhaled nitric oxide (FeNO) testing, effective April 1. HCSC provides …

    Published on 3/24/2014
  • Azano, Manhattan Scientifics sales and marketing update

    Azano Pharmaceuticals Inc., Albuquerque, N.M. Manhattan Scientifics Inc. (OTCQB:MHTX), New York, N.Y. Business: Diagnostic Manhattan Scientifics granted Azano exclusive, worldwide rights to commercialize NanoMRX …

    Published on 3/24/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993